USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Alpha Tau Medical Ltd.

USPTO PatentsView assignee record - 22 granted patents across 12 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).

22
Total patents granted
12
CPC technology areas
17.9
Avg claims per patent
+2000%
5-year filing velocity

The verdict

Alpha holds 22 US patents across 12 technology areas, rank #13,301 of 50,000 tracked assignees.

#13,301
of 50,000 US assignees by volume
Top 8%
by Innovation Score (53.8/100)
17.9
avg claims per patent
+2000%
filing velocity, last 5 yrs

Portfolio overview

Alpha Tau Medical Ltd. has been granted 22 US utility patents between 2018 and 2025, placing Alpha Tau Medical Ltd. at rank #13,301 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.9 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a Foreign Corporation, Alpha Tau Medical Ltd. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 53.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 21 grants, compared with 1 in the 2015–2019 window, a +2000% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Alpha Tau Medical Ltd.'s 17.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Alpha Tau Medical Ltd. against peers pursuing similar technology classes.

How does Alpha compare?

Granted US patents 2015–2025 versus the largest corporate holders, this company marked ◀

patents

What this shows Alpha holds 22 patents, placing it at rank #13,301 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Alpha's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

54 Top 8% higher than 92% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

051015 20182022202320242025 4
USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Alpha Tau Medical Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 1 4.5%
2022 1 4.5%
2023 2 9.1%
2024 14 63.6%
2025 4 18.2%

Which technologies does Alpha Tau Medical Ltd. patent most?

Top 12 of 12 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#13,301

Across all tracked assignees

Innovation Score

53.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Alpha Tau Medical Ltd. hold?
Alpha Tau Medical Ltd. holds 22 US granted patents filed between 2018 and 2025, spanning 12 technology areas.
What is Alpha Tau Medical Ltd.'s Innovation Score?
Alpha Tau Medical Ltd. has an Innovation Score of 53.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Alpha Tau Medical Ltd. focus on?
Alpha Tau Medical Ltd.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY) with 22 patents. The company has filed patents in 12 CPC subclasses total.
Is Alpha Tau Medical Ltd.'s patent filing rate increasing or decreasing?
Alpha Tau Medical Ltd.'s recent filing velocity is +2000% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Alpha Tau Medical Ltd.'s patents?
Alpha Tau Medical Ltd.'s patents average 17.9 claims each. This falls within the standard range, providing solid legal coverage.
How is the Alpha Tau Medical Ltd. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Guides to patent portfolio analysis

How to use this portfolio

Alpha's 22 grants land it in the top 8% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Alpha ranks #13,301 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61N - see who else leads that technology area. A61N leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov